Thermo Fisher Expands Gene Therapy Portfolio to Support AAV Manufacturing

A new media panel, gene kit, and advanced resins that are now in Thermo Fisher Scientific’s gene therapy portfolio aim to reduce manufacturing costs and increase gene therapy viability.